- 9 aprile 2021 - UNA PUBBLICAZIONE SU "COVID -19 E CANCRO: UN ABBINAMENTO MORTALE" USCITA SULL' INTERNATIONAL JOURNAL OF CANCER DEL 9 APRILE 2021 (U. TIRELLI E S. CHIRUMBOLO)
La mortalità per tumore, e così per certe malattie cardiovascolari come infarto e ictus, è incrementata per ritardi diagnostici e impossibilità a procedere alle terapie previste a causa del covid-19 (infezione concomitante di Sars-COV-2, mancanza di posti letto e di posti di terapia intensiva per infarti e ictus). - Proliferation in HHV-8-Positive Primary Effusion Lymphomas Is Associated with Expression of HHV-8 Cyclin but Independent of p27(kip1).
- Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study.
- Role of brain biopsy in the management of focal brain lesions in HIV-infected patients. Gruppo Italiano Cooperativo AIDS & Tumori.
- Molecular profile of epstein-barr virus infection in HHV-8-positive primary effusion lymphoma.
- Lung carcinoma in 36 patients with human immunodeficiency virus infection.
- Mutation of BAX occurs infrequently in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.
- Idiopathic chronic fatigue and chronic fatigue syndrome: a comparison of two case-definitions.
- HAART is effective as anti-Kaposi's sarcoma therapy only after remission has been induced by chemotherapy.
- Neoplastic complications of HIV infection.
- Therapy of non-small-cell lung cancer (NSCLC) in patients with HIV infection.
- Interactions of Antineoplastic Chemotherapy with Zidovudine Pharmacokinetics in Patients with HIV-Related Neoplasms.
- Hodgkin's disease in HIV-infected individuals.
- Combination therapy with alpha interferon and lamivudine in patients with chronic hepatitis B and HIV infection.
- Kinetics of lymphokine production in HIV+ patients treated with highly active antiretroviral therapy and interleukin 2.
- Debate on Di Bella therapy.
- Evaluation study of the opinion on Di Bella's multimodal therapy of patients with tumors.
- Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2.
- A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.
- The effects of CD40 ligation on peripheral blood mononuclear cell interleukin-12 and interleukin-15 production and on monocyte CD14 surface antigen expression in human immunodeficiency virus-positive patients.
- AIDS-associated Kaposi's sarcoma is more aggressive in women: a study of 54 patients.
- Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF.
- Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells.
- Dynamics of provirus load and lymphocyte subsets after interleukin 2 treatment in HIV-infected patients.
- Condom use in female sex workers in Italy.
- Concomitant therapy with subcutaneous interleukin-2 and zidovudine plus didanosine in patients with early stage HIV infection.
- The pathologic spectrum of AIDS-related non-Hodgkin’s lymphomas.
- Major cardiovascular events following infusional 5-fluorouracil and cisplatin antineoplastic therapy.
- Neoplastic disease.
- The role and activity of an Italian volunteer organization providing information and emotional support for patients with cancer.
- Discordant hhv8 detection in a young hiv-negative patient with kaposi's sarcoma and sarcoidosis.
- Chronic hepatitis C in HIV-coinfected patients: feasibility and efficacy of interferon-alpha2b and ribavirin combination therapy.
- Hodgkin's disease: clinical presentation and treatment.
- A 20-year experience on malignant lymphomas in patients aged 70 and older at a single institute.
- A 20-year experience on malignant lymphomas in patients aged 70 and older at a single institute.
- Primary effusion lymphoma cell lines harbouring human herpesvirus type-8.
- Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma.
- Human immunodeficiency virus-associated Hodgkin's disease.
- Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy.
- Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. ICONA Study Group. Italian Cohort of Antiretroviral Naive Patients.
- Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection.
- Effects of 2-year antiretroviral combination therapies on HIV-1 DNA levels.
- Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4+ at lymphocyte apoptosis in HIV+patients.
- Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection.
- Concomitant cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related non-Hodgkin lymphoma.
- Absence of an effect of herpes simplex virus type 2 infection on HIV disease progression: data from a cohort of HIV-positive individualks with known date of seroconversion.
- Hodgkin's disease: clinical presentation and treatment.
- A 20-year experience on malignant lymphomas in patients aged 70 and older at a single institute.
- Discordant hhv8 detection in a young HIV-negative patient with Kaposi's sarcoma and sarcoidosis.
- Chronic hepatitis C in HIV-coinfected patients: feasibility and efficacy of interferon-alpha2b and combination therapy.
- Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC Study.
- Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas.
- Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy.
- Response to highly active antiretroviral therapy according to duration of HIV infection.
- Lymphocyte subsets and viral load in patients with HIV-associated non-Hodgkin's lymphoma treated with anti-CD20 monoclonal antibody and chemotehrapy.
- Human immunodeficiency virus-related non-Hodgkin's lymphoma: activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients.
- 56. Impact of HAART on the clinical management of AIDS-related cancers.
- 57. Clinical aspects and management of Hodgkin's disease and other tumors in HIV-infected individuals.
- 58. Chronic hepatitis C in HIV-coinfected patients: feasibility and sustained efficacy of therapy with interferon alpha-2b and ribavirin.
- 59. Cervical cancer in HIV.
- 60. Management of hematologic malignancies in the elderly: 15-year experience at the Aviano Cancer Center, Italy.
- 61. I linfomi non-Hodgkin-HIV sistemici nell'era dell'HAART. Storia naturale.
- 62. Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART.
- 63. Infusional CDE with rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: preliminary results of a phase I/II study.
- 64. Neoplastic complications of AIDS.
- 65. AIDS-related tumors: integrating antiviral and anticancer therapy.
- 66. Relevance of intraocular involvement in the management of primary central nervous system lymphomas.
- 67. Elderly head and neck (H-N) cancer patients: a monoinstitutional series.
- 68. Non-Hodgkin's lymphoma in the elderly.
- 69. Hodgkin's disease in the elderly: current status and future directions.
- 70. A multicenter study of treatment of primary CNS lymphoma.
- 71. Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose intensity of doxorubicin and cyclophosphamide
- 72. Differentation between non-Hodgkin's lymphoma ercurrence and second primary lymphoma by VDJ rearrangement analysis.
- 73. Expression of cyclin-dependent kinase inhibitor p27Kip1 in AIDS-related diffuse large-cell lymphomas is associated with Epstein-Barr virus-encoded latent membrane protein 1.
- 74. Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.
- 75. Cancer-related fatigue.
- 76. Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin's lymphoma.
- 77. No Protective effects of acyclovir on HIV disease progression in a cohort of HSV-2-HIV-infected individuals.
- 78. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
- 79. Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV seroconverters.
- 80. Comprehensive geriatric evaluation in elderly patients with lymphoma: feasibility of a patient-tailored treatment plan.
- 81. Rituximab and chemotherapy is highly effective in patients with CD20-positive non Hodgkin's lymphoma and HIV infection.
- 82. High international prognostic score predicts a worse outcome for patients with Hodgkin's disease and HIV infection: results of a prospective study with Stanford V regimen.
- 83. Interferon-gamma secretion and perforin expression are impaired in CD8+ T lymphocytes from patients with undifferentiated carcinoma of nasopharyngeal type.
- 84. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
- 85. Involved-field radiotherapy for advanced Hodgkin's lymphoma.
- 86. Hodgkin's disease in HIV.
- 87. AIDS-related Kaposi's sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the HAART era - the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive from Antiretrovirals
- 88. Therapeutic approaches to AIDS-related malignancies
- 89. Impact of concomitant antiblastic chemotherapy and highly active antiretroviral therapy on human immunodeficiency virus (HIV) viremia and genotyping in HIV-infected patients with non-Hodgkin's lymphoma.
- 90. Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy.
- 91. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single institution study
- 92. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy.
- 93. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi’s sarcoma.
- 94. Outcome in patients with no-hodgkin lymphoma and with or without human immunodeficiency virus infection
- 95. Long-term efficacy of the CHVmP/BV regimen used for aggressive non-Hodgkin's lymphoma in three randomised EORTC trials
- 96. Mitoxantrone, vinorelbine and prednisone (MVD) in the treatment of metastatic hormonoresistant prostate cancer--a phase II trial
- 97. Virological efficacy in HIV-infected patients affected by non-Hodgkin lymphoma, treat with antiblastic chemotherapy and highly active antiretroviral therapy
- 98. Efficacy and safety of combined treatment with pegylated.IFN-alpha2b plus rebavirin in HIV-hepatitis C virus-co-infected patients
- 99. Improving information to Italian cancer patients: results of a randomized study
- 100. Tumori solidi
- 101. HIV-related non-Hodgkin's lymphoma (HIV-NHL) in the era of highly active antiretroviral therapy (HAART): some still unanswered questions for clinical management.
- 102. Rituximab-CHOP or 2 weekly CHOP + G-CSF in aggressive lymphoma of the elderly?
- 103. Hepatitis C virus infection does not prevent autologous bone marrow transplantation in HIV related non-Hodgkin's lymphoma
- 104. Fatigue in cancer
patients receiving chemotherapy: analysis of published
studies.
Fatigue in Cancer - review - 105. Rituximab plus
infusional cyclophosphamide, doxorubicin and etoposide (R-CDE)
in HIV-associated non-Hodgkin's lymphoma: pooled results
from three phase II trials.
- 106. Effect of highly
active antiretroviral therapy (HAART) on
pharmacokinetics and pharmacodynamics of doxorubicin in
patients with HIV-associated non-Hodgkin's lymphoma.
- 107. Treatment of head and
neck cancer in elderly patients: state of the art and
guidelines.
- 108. Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus Type 8-Positive Solid Lymphomas: A Tissue-Based Variant of Primary Effusion Lymphoma.
- 109. Dysphonia as an unusual toxic event of oxaliplatin-based chemotherapy.
- 110. Pharmacokinetic interaction between chemotherapy for non-Hodgkin's lymphoma and protease inhibitors in HIV-1-infected patients.
- 111. Hepatitis C virus and non-Hodgkin's lymphoma 10 years later.
- 112. Is high-dose chemotherapy with peripheral stem cell rescue a suitable option for elderly patients affected by aggressive non-Hodgkin's lymphoma?
- 113. Cancer Prevention and Early Diagnosis in HIV-Positive Individuals.
- 114. Highly Active Antiretroviral Therapy in AIDS-Associated Kaposi's Sarcoma (KS): Implications for the Design of Therapeutic Trials in Patients With Advanced Symptomatic KS.
- 115. Characterization of immunologic and virological parameters in HIV-infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy.
- 116. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study.
- 117. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma.
- 118. Trends in cancer incidence rates among HIV-infected patients.
- 119. Regression of low-grade non-Hodgkin's lymphoma after treatment with pegylated interferon plus ribavirin in hepatitis C virus infection.
- 120. Cancer and aging: are there any differences in the information needs of elderly and younger patients? Results from an Italian observational study.
- 121. Rituximab for HIV-associated lymphoma: weighing the benefits and risks.
- 122. Gefitinib in patients with non-small cell lung cancer: Symptomatic improvement within a few days.
- 123. KSHV/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects. Report of two cases with anaplastic large cell morphology and plasmablastic immunophenotype.
- 124. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.
- 125. Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials.
- 126. Patients with HIV with Burkitt's lymphoma have a worse outcome than those with diffuse large-cell lymphoma also in the highly active antiretroviral therapy era.
- Liver resection of metastasis by colorectal cancer in a HIV patient.
- 128. Oxaliplatin-based chemotherapy in association with highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients
- 129. Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas.
- 130. Prognostic factors in human herpesvirus 8-related lymphoproliferative disorders associated with HIV infection.
- 131. Keynote comment: reimbursement for molecularly targeted anticancer agents
- 132. A spindle cell variant of diffuse large B-cell lymphoma possesses genotypic and phenotypic markers characteristic of a germinal center B-cell origin.
- 133. AIDS-related non-Hodgkin's lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy.
- 134. Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.
- 135. Treatment of elderly cancer patients: a planet in evolution.
- 136. Multidisciplinary approach in a HIV/HCV-positive patient with liver metastases by colorectal cancer in the HAART era.
- 137. Interleukin-2 continuous infusion and angiogenesis surrogate markers in metastatic renal cell carcinoma.
- 138. Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention.
- 139. Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era.
- 140. Insight into the treatment of cancer in older patients: Developments in the last decade.
- 141. FOLFOX2 regimen in the treatment of advanced colorectal cancer: a comparison between elderly and young patients.
- 142. Metastatic angiosarcoma of the kidney: a case report with treatment approach and review of the literature.
- 143. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
- 144. Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma
- 145. Impact of involved field radiotherapy in partial response after doxorubicin-based chemotherapy for advanced aggressive non-Hodgkin's lymphoma.
- 146. What elderly cancer patients want to know? Differences among elderly and young patients
- 147. Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC).
- 148. A pilot project of a cancer patient library in Italy: results of a customer-satisfaction survey and its products.
- 149. Ifosfamide,
gemcitabine, and vinorelbine: a new induction regimen
for refractory and relapsed Hodgkin's lymphoma.
Haematologica. 2007 Jan;92(1):35-41. - 150. Reduced-intensity
allogeneic transplantation in patients with refractory
or progressive Hodgkin's disease after high-dose
chemotherapy and autologous stem cell infusion.
Eur J Haematol. 2007 Jan 23 - 151. Phase II trial of
CHOP plus rituximab in patients with HIV-associated
non-Hodgkin's lymphoma.
J Clin Oncol. 2007 Feb 20;25(6):e7. - 152. Cetuximab/targeted
chemotherapy in an HIV-positive patient with metastatic
colorectal cancer in the HAART era: a case report.
J Chemother. 2007 Jun;19(3):343-6. - 153. Lopinavir-Ritonavir
Dramatically Affects the Pharmacokinetics of Irinotecan
in HIV Patients With Kaposi's Sarcoma.
Clin Pharmacol Ther. 2007 Aug 22 - 154. Role
of the HLA class II: HCV-related disorders.
Ann N Y Acad Sci. 2007 Jun;1107:308-18. - 155. IGEV
regimen and a fixed dose of lenograstim: an effective
mobilization regimen in pretreated Hodgkin's lymphoma
patients.
Bone Marrow Transplant. 2007 Oct 1 - 156.Recent
thymic emigrants in lymphoma patients with and without
human immunodeficiency virus infection candidates for
autologous peripheral stem cell transplantation.
Clin Exp Immunol. 2007 Oct 11 - 157. High
relapse rate after a brief chemotherapy course and
involved-field radiotherapy in early-stage Hodgkin
lymphoma.
Leuk Lymphoma. 2007 Oct 9 - 158. Bearz A, Serraino D, Fratino L, Berretta M, Tirelli U.
Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy.
Cancer. 2007 Oct 25 - 159. Chemotherapy plus involved-field radiation in
early-stage Hodgkin's disease.
N Engl J Med. 2007 Nov 8;357(19):1916-27 - 160. Pemetrexed single agent in previously treated
non-small cell lung cancer: A multi-institutional
observational study.
Lung Cancer. 2007 Nov 16 - 161. Etiologic treatment of hepatitis C virus-associated
mixed cryoglobulinemia.
Dig Liver Dis. 2007 Sep;39 Suppl 1:S102-6. - 162. The
impact of tobacco smoking and alcohol drinking on
survival of patients with non-Hodgkin lymphoma.
Int J Cancer. 2007 Dec 4 - 163. MUC-1 (CA
15-3 antigen) as a highly reliable predictor of response
to EGFR inhibitors in patients with bronchioloalveolar
carcinoma: an experience on 26 patients.
Int J Biol Markers. 2007 Oct-Dec;22(4):307-11. - 164. Clinical
management of long-term cancer survivors.
J Clin Oncol. 2008 Jan 1;26(1):161-2 - 165. Can the caregiver replace his/her elderly cancer patient
in the physician-patient line of communication?
Support Care Cancer. 2008 Jan 29 - 166. Distinct
functional significance of Akt and mTOR constitutive
activation in mantle cell lymphoma.
Blood. 2008 May 15;111(10):5142-51. - 167. Use of
nucleoside reverse transcriptase inhibitors and risk of
myocardial infarction in HIV-infected patients enrolled
in the D:A:D study: a multi-cohort collaboration.
Lancet. 2008 Apr 26;371(9622):1417-26. - 168. Self-reported sexual dysfunction is frequent among
HIV-infected persons and is associated with suboptimal
adherence to antiretrovirals.
AIDS Patient Care STDS. 2008 Apr;22(4):291-9. - 169. Changes
over time in risk factors for cardiovascular disease and
use of lipid-lowering drugs in HIV-infected individuals
and impact on myocardial infarction.
Clin Infect Dis. 2008 Apr 1;46(7):1101-10. - Cancer
survivorship: a challenge for the European
oncologists.
Ann Oncol. 2008 Jun 4 - 171. Molecular
analysis of immunoglobulin variable genes in human
immunodeficiency virus-related non-Hodgkin's lymphoma
reveals implications for disease pathogenesis and
histogenesis.
Haematologica. 2008 Jun 12 - 172. Adjuvant
radiotherapy on older and oldest elderly rectal cancer
patients.
Arch Gerontol Geriatr. 2008 Jun 21 - 173. FOLFOX-4
regimen with concomitant highly active antiretroviral
therapy in metastatic colorectal cancer HIV-infected
patients: a report of five cases and review of the
literature.
Cancer Invest. 2008 Jul;26(6):610-4. Review. - 174. Bevacizumab plus irinotecan-, fluorouracil-, and
leucovorin-based chemotherapy with concomitant HAART in
an HIV-positive patient with metastatic colorectal
cancer.
Onkologie. 2008 Jul;31(7):394-7 - 175. FOSFOX2 in
the treatment of advanced colorectal cancer: a
comparison between elderly and middle aged patients.
J Chemother. 2008 Aug;20(4):503-8. -
176. Genetic polymorphisms
differently influencing the emergence of atrophy and fat
accumulation in HIV-related lipodystrophy.
AIDS. 2008 Sep 12;22(14):1769-78 -
177. Clinical outcome and prognostic factors for patients treated
within the context of a phase I study: the Royal Marsden
Hospital experience.
Br J Cancer. 2008 Sep 9. -
178. Unusual presentation of metastatic hepatocellular
carcinoma in an HIV/HCV coinfected patient: case report
and review of the literature.
Tumori. 2008 Jul-Aug;94(4):589-91. - 179. HIV-induced
immunodeficiency and mortality from AIDS-defining and
non-AIDS-defining malignancies.
AIDS. 2008 Oct 18;22(16):2143-53. - 180. Does
short-term virologic failure translate to clinical
events in antiretroviral-naïve patients initiating
antiretroviral therapy in clinical practice?
AIDS. 2008 Nov 30;22(18):2481-92. - 181. Cancer
in the elderly: The caregivers' perception of senior
patients' informational needs.
Arch Gerontol Geriatr. 2008 Dec 11. - 182. Pegylated-interferon plus ribavirin for HCV-positive
indolent non-Hodgkin lymphomas
Br J Haematol. 2009 Feb 12. - 183. Variable
impact on mortality of AIDS-defining events diagnosed
during combination antiretroviral therapy: not all
AIDS-defining conditions are created equal.
Clin Infect Dis. 2009 Apr 15;48(8):1138-51. - 184. Plasma
HHV-8 viral load in HHV-8-related lymphoproliferative
disorders associated with HIV infection.
J Med Virol. 2009 May;81(5):888-96. - 185. Safety
and feasibility of radiotherapy treatment in elderly
non-small-cell lung cancer (NSCLC) patients.
Arch Gerontol Geriatr. 2009 Apr 30. - Leiomyosarcoma
of the parotid gland in an HIV-positive patient:
therapeutic approach, clinical course and review of the
literature.
J Chemother. 2009 Apr;21(2):215-8. - 187. Human
immunodeficiency virus-associated precursor
T-lymphoblastic leukemia/lymphoblastic lymphoma: report
of a case and review of the literature.
Hum Pathol. 2009 May 6. - 188. High dose
therapy and autologous peripheral blood stem cell
transplantation as salvage treatment for AIDS-related
lymphoma: long term results of the GICAT study with
analysis of prognostic factors.
Blood. 2009 May 18. - 189. Clinical
presentation and outcome of colorectal cancer in
HIV-positive patients: a clinical case-control study.
Onkologie. 2009 Jun;32(6):319-24. Epub 2009 May 14.
Comment in: Onkologie. 2009 Jun;32(6):306-7. - 190. Viral interference between hepatitis B, C, and D
viruses in dual and triple infections in HIV-positive
patients.
J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):574-81. - 191. Risk of developing specific AIDS-defining illnesses in patients
coinfected with HIV and hepatitis C virus with or without liver
cirrhosis.
Clin Infect Dis. 2009 Aug 15;49(4):612-22.
Comment in: Clin Infect Dis. 2009 Aug 15;49(4):623-5. - 192. Glioblastoma in elderly patients: Safety and efficacy of
adjuvant radiotherapy with concomitant temozolomide.
Arch Gerontol Geriatr. 2009 Jul 21. - 193. Activity of
Pemetrexed on brain metastases from Non-Small Cell
.Lung Cancer. 2009 Jul 24. - 194. Market
and patient access to new oncology products in Europe: a
current, multidisciplinary perspective.
Ann Oncol. 2009 Aug;20(8):1445.
Comment on: Ann Oncol. 2009 Mar;20(3):403-12. - 195. Assessing cancer-related fatigue: the psychometric properties of
the Revised Piper Fatigue Scale in Italian cancer inpatients.
Support Care Cancer. 2009 Sep 26. - 196. Quality of life after successful treatment of
early-stage Hodgkin's lymphoma: 10-year follow-up of the
EORTC-GELA H8 randomised controlled trial.
Lancet Oncol. 2009 Oct 12. - 197. Genome wide DNA-profiling of HIV-related B-cell lymphomas.
Br J Haematol. 2009 Oct 12. - 198. Management
of immunocompetent patients with primary central nervous
system lymphoma.
Clin Lymphoma Myeloma. 2009 Oct;9(5):353-64. - 199. Mortality from
HIV and TB coinfections is higher in Eastern Europe than
in Western Europe and Argentina.
Collaborators (353)
AIDS. 2009 Nov 27;23(18):2485-95. - 200. AIDS-Related Kaposi's Sarcoma: State of the Art and Therapeutic
Strategies.
Curr HIV Res. 2009 Nov;7(6):634-8. - 201. Comprehensive cancer control-research & development: knowing what we
do and doing what we know.
Tumori. 2009 Sep-Oct;95(5):610-22. - 202. Biomarkers in
neuroendocrine tumors.
Front Biosci (Schol Ed). 2010 Jan 1;2:332-42. - 203. Biological and
clinical markers in colorectal cancer: state of the art.
Front Biosci (Schol Ed). 2010 Jan 1;2:422-31. - 204. Safety and
efficacy of radiotherapy treatment in elderly patients
with localized prostate cancer: A retrospective
analysis.
Arch Gerontol Geriatr. 2009 Dec 29. - 205. Phase 2 study
of intrathecal, long-acting liposomal cytarabine in the
prophylaxis of lymphomatous meningitis in human
immunodeficiency virus-related non-Hodgkin lymphoma.
Cancer. 2010 Jan 27. - 206. Predictive
Value of HIV Type 1 DNA Levels on Overall Survival in
HIV-Related Lymphoma Patients Treated with High-Dose
Chemotherapy (HDC) Plus Autologous Stem Cell
Transplantation (ASCT).
AIDS Res Hum Retroviruses. 2010 Feb;26(2):245-51. - 207. Clinical
presentation and outcome of colorectal cancer in
HIV-positive patients: a clinical case-control study.
Onkologie. 2009 Jun;32(6):319-24. - 208. FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: A prospective study.
Arch Gerontol Geriatr. 2010 Mar 6. - 209. Incidence of
malignancies in HIV-infected patients and prognostic role of
current CD4 cell count: evidence from a large Italian cohort
study.
Clin Infect Dis. 2010 May 1;50(9):1316-21. - 210. HIV-positive
patients with liver metastases from colorectal cancer deserve
the same therapeutic approach as the general population.
Onkologie. 2010;33(4):203-4. - 211.
Immune recovery after autologous stem cell transplantation is
not different for HIV-infected versus HIV-uninfected patients
with relapsed or refractory lymphoma.
Clin Infect Dis. 2010 Jun 15;50(12):1672-9. - 212. Biomarkers in lung
cancer.
Front Biosci (Elite Ed). 2010 Jun 1;2:1099-104. - 213.
The revised piper
fatigue scale (PFS-R) for Italian cancer patients: a validation
study.
Tumori. 2010 Mar-Apr; 96(2):276-81. - 214.
Rate of CD4+ cell count increase
over periods of viral load suppression: relationship with the
number of previous virological failures.
Clin Infect Dis. 2010 Aug 15;51(4):456-64. - 215.
Therapeutic options for
HIV-associated lymphomas.
Expert Opin Pharmacother. 2010 Aug 23. - 216.
Stem cell
transplantation for lymphoma patients with HIV Infection.
Cell Transplant. 2010 Sep 27. - 217. Hodgkin's
Disease in Patients with HIV Infection.
Adv Hematol. 2010 Sep 23. - 218. HIV-Infected
Patients and Liver Transplantation: Who, When and Why.
Curr HIV Res. 2011 Jan 11. - 219. Favourable evolution of virological and immunological
profiles in treated and untreated patients in Italy in the
period 1998-2008.
HIV Med. 2011 Mar;12(3):174-82. - 221. Mutations of CD79A, CD79B and EZH2 genes in
immunodeficiency-related non-Hodgkin lymphomas.
Br J Haematol. 2011 Jan 30. - 222. Long term survival in a patient with adenocarcinoma of
the cystic duct.
J Chemother. 2011 Jan;22(6):436-7. - 223. Small cell lung cancer in an elderly patient: efficacy
of somatostatin analog treatment, a case report.
Onkologie. 2011;34(3):117-20. - 224. .HIV-Infected Patients and Liver Transplantation: Who,
When and Why.
Curr HIV Res. 2011 Feb 15. - 225. Classical Hodgkin's lymphoma arising in different host's
conditions: pathobiology parameters, therapeutic options, and
outcome.
Am J Hematol. 2011 Feb;86(2):170-9. - 226. Long-term CD4+
T-cell count evolution after switching from regimens including
HIV nucleoside reverse transcriptase inhibitors (NRTI) plus
protease inhibitors to regimens containing NRTI plus non-NRTI or
only NRTI.
BMC Infect Dis. 2011 Jan 25;11:23. - 227. Anal
Cancer: Focus on HIV-Positive Patients in the HAART-Era.
Curr HIV Res. 2011 Mar 1;9(2):70-81 - 228. Target
therapies in lung cancer.
J Biomed Biotechnol. 2011;2011:921231. - 229. Genomic aberrations affecting the outcome of
immunodeficiency-related diffuse large B-cell lymphoma.
Leuk Lymphoma. 2011 Aug 28. - 230. Long-term cancer survivorship: a new challenge that requires a
new follow-up approach..
Eur Rev Med Pharmacol Sci. 2011 Jun;15(6):725-6. - 231. Oxaliplatin-based chemotherapy in the treatment of elderly
patients with metastatic colorectal cancer (CRC).
Arch Gerontol Geriatr. 2011 Sep 19. - 232. Hepatocellular Carcinoma in HIV-Infected Patients: Check Early,
Treat Hard.
Oncologist. 2011;16(9):1258-69. - 234. Mycobacterium tuberculosis: an infection we should suspect in
bone marrow transplantation.
J Chemother. 2011 Oct;23(5):312-3 - 235. Symptom burden in cancer survivors 1 year after diagnosis: A
report from the american cancer society's studies of cancer
survivors.
Cancer 2011 Aug 25. - 236.
Adjuvant radiotherapy on older and oldest breast cancer patients
after conservative surgery: A retrospective analysis.
Arch Gerontol Geriatr. 2011 Oct 28. - 237. Grouping of molecularly targeted anti-cancer agents based on
cost-effectiveness analysis.
Eur Rev Med Pharmacol Sci. 2011 Nov;15(11):1355-6. - 238. The role of diet in gastric cancer: still an open question.
Front Biosci. 2012 Jan 1;17:1640-7. - 239.
The role of nutrition in the development of esophageal cancer:
what do we know?
Front Biosci (Elite Ed). 2012 Jan 1;4:351-7. - 240. Two types of fatigue in cancer patients.
BJ Cancer. 2012 Jan 17;106(2):424. . - 241. Assessment of immunovirological features in HIV related
non-Hodgkin lymphoma patients and their impact on outcome.
J Clin Virol. 2012 Jan 11. - 242. Viral tropism by geno2pheno as a tool for predicting CD4
decrease in HIV-1-infected naive patients with high CD4 counts.
J Antimicrob Chemother. 2012 May;67(5):1224-7. - 243. Oncologic drug shortages also in Italy. Eur Rev Med Pharmacol Sci. 2012 Jan;16(1):138-9.
- 244. Alterations of negative regulators of cytokine signalling in
immunodeficiency-related non-Hodgkin lymphoma.
Hematol Oncol. 2012 Apr 9. - 245. Comment on 'Lung cancer in the Swiss HIV Cohort Study: role of
smoking, immunodeficiency and pulmonary infection'.
Br J Cancer. 2012 May 3. - 246. Modulated Chemotherapy According to Modified Comprehensive
Geriatric Assessment in 100 Consecutive Elderly Patients with
Diffuse Large B-Cell Lymphoma.
Oncologist. 2012 May 18. - 247. Pancreatic
Cancer in HIV-Positive Patients: A Clinical Case-Control Study.
Pancreas. 2012 Jun 24 - 248.
Exposure to abacavir and biomarkers of cardiovascular disease in
HIV-1-infected patients on suppressive antiretroviral therapy: a
longitudinal study.
J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):e98-101. - 249. Multiplex analysis of blood cytokines as a prognostic
tool in HIV related non-Hodgkin lymphoma patients: A potential
role of interleukin-7.
Cytokine. 2012 Jul 12. - 250. Knowledge and skills needs for health professions about
pharmacogenomics testing field.
Eur Rev Med Pharmacol Sci. 2012 Jun;16(6):781-8. - 251.
Safety and activity of a new intensive short-term
chemoimmunotherapy in HIV-positive patients with Burkitt
lymphoma.
Br J Haematol. 2012 Oct;159(2):252-5. - 252. Re-challenge with pemetrexed in advanced mesothelioma: a
multi-institutional experience.
BMC Res Notes. 2012 Sep 3;5(1):482. - 253. An overview of viral oncology in Italy - report from the Pavia
meeting on solid tumors
Infect Agent Cancer. 2012 Sep 5;7(1):23. - 254.
Time trends of cancer mortality among elderly in Italy,
1970--2008: an observational study.
BMC Cancer. 2012 Oct 2;12(1):443. - 255.
Clinical presentation and outcome of squamous cell carcinoma of
the anus in HIV-infected patients in the HAART-era: a GICAT
experience.
Eur Rev Med Pharmacol Sci. 2012 Sep;16(9):1283-1291. - 256.
Is long-term fatigue in patients with cancer an infrequent
symptom?
J Clin Oncol. 2012 Nov 20;30(33):4175; - 257. Predicting the short-term risk of diabetes in HIV-positive
patients: the Data Collection on Adverse Events of Anti-HIV
Drugs (D:A:D) study.
J Int AIDS Soc. 2012 Oct 10;15(2):17426. - 258.Comorbidity assessment and radiotherapy in elderly cancer
patients.
Eur Rev Med Pharmacol Sci. 2012 Oct;16(11):1605-6. - 259. Quality of life analysis of TORCH, a randomized trial testing
first-line erlotinib followed by second-line cisplatin/gemcitabine
chemotherapy in advanced non-small-cell lung cancer.
J Thorac Oncol. 2012 Dec;7(12):1830-44. - 260.
Sorafenib for the treatment of unresectable hepatocellular
carcinoma in HIV-positive patients.
Anticancer Drugs. 2013 Feb;24(2):212-8. - 261. Nutrition in oncologic patients during antiblastic treatment.
Front Biosci. 2013 Jan 1;18:120-32. - 262. Antiblastic treatment, for solid tumors, during pregnancy: a
crucial decision.
Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2 Suppl):1S-19S. - 263. Antiblastic treatment of haematological malignancies during
pregnancy: a crucial decision.
Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2 Suppl):21S-32S. - 264. Obstetrical, fetal and postnatal effects of gestational
antiblastic chemotherapy: how to counsel cancer patients.
Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2 Suppl):33S-46S. - 265. Nodular lymphocyte predominant Hodgkin lymphoma with
non-invasive or early invasive growth pattern suggests an early
step of the disease with a highly favorable outcome.
Am J Hematol. 2013 Feb;88(2):161-2. - 266. Contribution of genetic background, traditional risk factors,
and HIV-related factors to coronary artery disease events in
HIV-positive persons.
Clin Infect Dis. 2013 Jul;57(1):112-21. - 267. Multicenter italian experience in liver transplantation for
hepatocellular carcinoma in HIV-infected patients.
Oncologist. 2013;18(5):592-9. - 268. Beyond semantics: the need to better categorize patients with
cancer.
J Clin Oncol. 2013 Jul 10;31(20):2637-8. - 269. Risk of clinical progression among patients with immunological
nonresponse despite virological suppression after combination
antiretroviral treatment.
AIDS. 2013 Mar 13;27(5):769-79. - 270. Cancer patients and survivors: changing words or changing
culture?
Ann Oncol. 2013 Jun 24. - 271. Cancer-related fatigue in the elderly.
Support Care Cancer. 2013 Jul 13. - 272. Stem cell
mobilization in HIV seropositive patients with lymphoma.
Haematologica. 2013 Aug 23. - 273. Treatment
factors affecting outcomes in HIV-associated non-Hodgkin
lymphomas: a pooled analysis of 1,546 patients.
Blood. 2013 Sep 6. - 274. Capitolo su Esmo handbook of Cancer Treatments in special clinical situation: Cancer Treatment in Patients with HIV.
- 275. Kaposi' s sarcoma in HIV-positive patients: the state of art in
the HAART-era.
Eur Rev Med Pharmacol Sci. 2013 Sep;17(17):2354-65. - 276. Management of
elderly patients with diffuse large B-cell lymphomas.
Anticancer Agents Med Chem. 2013 Nov;13(9):1412-8. - 277. Autologus stem cell transplatation as a care option in elderly
patients. A review.
Anticancer Agents Med Chem. 2013 Nov;13(9):1419-29. - 278. Treatment of Elderly Patients Affected by Lung Cancer: Why to Treat, when to Treat and what we Know.
- 279. Colorectal cancer in elderly patients: from best supportive care
to cure.
Anticancer Agents Med Chem. 2013 Nov;13(9):1332-43.
280. Oxaliplapin and Capecitabine (XELOX) Based Chemotherapy in the Treatment of Metastatic Colorectal Cancer: The Right Choice in Elderly Patients.
Anticancer Agents Med Chem. 2013 Nov;13(9):1344-53. - 281. Onco-surgical management of colo-rectal liver metastases in
older patients: a new frontier in the 3rd millennium.
Anticancer Agents Med Chem. 2013 Nov;13(9):1354-63. - 283. Hepatocellular carcinoma: beyond the boundaries of age.
Anticancer Agents Med Chem. 2013 Nov;13(9):1371-7. - 284 Editorial: elderly cancer patients in the 3rd millenium: between
hope and reality.
Anticancer Agents Med Chem. 2013 Nov;13(9):1299 - 285. Treatment of 741 italian
patients with chronic fatigue syndrome.
Eur Rev Med Pharmacol Sci. 2013 Nov;17(21):2847-52. - 286. Is It Better to Transfer Long-Term Cancer Survivors to General
Practitioner or Develop Clinics for Long-Term Survivors Within the Cancer
Centers?
J Clin Oncol. 2013 Dec 2. - 287. Recurrence of breast cancer in elderly women. .
J Clin Oncol. 2014 Jan 10;32(2):161. - 288. Immune
activation and microbial translocation in liver disease
progression in HIV/hepatitis co-infected patients: results from
the Icona Foundation study.
BMC Infect Dis. 2014 Feb 12;14:79. - 289. Cancer
survivorship: Is there a role for cancer survivor clinics?
Cancer. 2014 Mar 11. - 290. Which tools may help physicians in female fertility prediction
after autologous bone marrow transplantation for lymphoma? A
pilot study.
J Chemother. 2014 Jan 21 - 291. Feasibility of intraperitoneal Trastuzumab treatment in a
patient with peritoneal carcinomatosis from gastric cancer.
Eur Rev Med Pharmacol Sci. 2014 Mar;18(5):689-92. - 292. Access to cancer care: the cost of treatment matters. Recenti Prog Med. 2014 May;105(5):181-3.
- 293. Head and neck
cancer survivors patients and late effects related to oncologic
treatment: update of literature.
Eur Rev Med Pharmacol Sci. 2014;18(10):1473-81. - 294. Trends in underlying causes of death in people with HIV from
1999 to 2011 (D:A:D): a multicohort collaboration.
Lancet. 2014 Jul 19;384(9939):241-8. - 295. Reply to long-term survivorship clinics led by primary care
physicians within the cancer center may be a good option for
coordinated survivorship care.
Cancer. 2014 Jul 24. - 296. Long-term
survival, prevalence, and cure of cancer: A population-based
estimation for 818,902 Italian patients and 26 cancer types.
Ann Oncol. 2014 Aug 22. - 297. A new
prognostic score for AIDS-related lymphomas in the
Rituximab-era.
Haematologica. 2014 Aug 22. pii: haematol.2014.111112. - 298. Activity of
crizotinib over choroidal metastases in non-small-cell lung
cancer (NSCLC)-ALK rearranged: a case report..
BMC Res Notes. 2014 Sep 2;7:589. - 299. Survivorship
Care Plans: A Change of Perspective or a Failure.
J Clin Oncol. 2014 Sep 22. -
300. Autograft HIV-DNA load predicts HIV-1 peripheral reservoir after stem cell transplantation for AIDS-related lymphoma patients.
AIDS Res Hum Retroviruses. 2015 Jan;31(1):150-9. -
301. Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.
Ann Oncol. 2015 Jan 28. -
302. Is long-term cancer survivors' quality of life comparable to that of the general population? An italian study. Support Care Cancer.
-
303 γ-Herpesvirus Load as Surrogate Marker of Early Death in HIV-1 Lymphoma Patients Submitted to High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation.
PLoS One. 2015 Feb 10;10(2) -
304. PET-adapted salvage therapy in Hodgkin's lymphoma.
Lancet Oncol. 2015 Mar;16(3):239-40. -
305. Prognostic value of PUMA expression in patients with HBV-related hepatocellular carcinoma.
Eur Rev Med Pharmacol Sci. 2015 Jan;19(1):38-44. -
306.The long and winding road in cancer survivorship care.
Cancer. 2015 Jul 2. -
307. Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma.
Eur Rev Med Pharmacol Sci. 2015 Jul;19(14):2521-2.